Monday, April 27, 2020 07:41 PM

21 CLINICAL TRIALS OF TESTOSTERONE THERAPY GIVEN TO MEN WITH PROSTATE CANCER: THE RESULTS - ANTI AGING NEWS

Starting in the 1950s, it was believed that testosterone therapy increased the risk of prostate cancer in men. This assumption was based on an anecdotal study of one male patient who had undergone castration years earlier and developed prostate cancer after receiving testosterone therapy. It seems indeed that men who have been castrated for a long time are less likely to have prostate cancer because their prostate is almost completely atrophied. When later testosterone therapy is given, the prostate develops again and may become a target for cancer because of the increase in tissue. However, this condition is exceptional, and the great majority of other cases of men with normally well-developed prostate show the opposite: that testosterone protects their prostate. Particularly, men with higher testosterone levels have less risk of aggressive prostate cancer, and testosterone therapy does not increase the risk of prostate cancer.

Recent studies in support of neutral effects of testosterone therapy in prostate cancer patients:

For this reason, top urologists and andrologists from all over the world have started to administer testosterone to men with treated and untreated (still active) prostate cancer. Kardoust Parizi and colleagues in their review of the literature, published in October 2019, found 21 clinical ...

News source: GOOGLE NEWS

See also: Associated Urologists Nashville